A high-tech device that can monitor medication use and compliance has been cleared by the FDA for use with AstraZeneca’s Airsupra and Breztri inhalers. Developed by Australian medtech firm Adherium, ...

- The collaboration will leverage General Proximity's OmniTAC platform to identify and advance next generation induced proximity agents for high value oncology targets. - Induced proximity medicines, ...